OCTRI Pilot Project Awards 2017


iPancreas: Internet based on-demand artificial pancreas app-generator to accelerate clinical trials research

Biomedical Innovation Program

The Biomedical Innovation Program (BIP) is designed to accelerate the movement of healthcare technologies from academia to the marketplace. In 2017, OCTRI will fund three collaborative, innovative pilot projects that address significant healthcare problems. The BIP is a collaboration between OCTRI and Technology Transfer & Business Development (TTBD), with additional funding and support from industry partners, Welch-Allyn, and GE Healthcare. 

David Huang

Dry Eye Treatment Device

David Sheridan 

Wearable Monitoring for Mental Health Patients

David Simons 

Glaucoma Tube Implant with Modulated Flow

Biomedical Innovation Program Drug Discovery

This track of BIP funding supports drug discovery platforms and early stage therapeutic technology projects, such as validation of drug targets, small molecules, vaccines, antibodies, and biologics. The BIP Drug Discovery program is a collaboration between OCTRI, Technology Transfer & Business Development (TTBD), and the OHSU Knight Cancer Institute.  

Monika Davare

Development of a 'hit to lead' compound as a therapeutic agent to treat Ewing's sarcoma and subsets of hematological malignancies

Beth Habecker & Michael Cohen

Novel compositions targeting protein tyrosine phosphatase sigma for nerve regeneration